Substance abuse is a severely debilitating disorder that results in significant liabilities for an orderly society. These include not only the individual and the personal consequences resulting from such abuse, but also secondary effects such as the illegal activities related to procurement, as well as decreased productivity that follows an individual's loss of control to compulsive drug use. Although significant advances in treatment have been accomplished, there is still a great deal to understand and implement. The effective and efficient treatment and prevention of substance abuse could be assisted with further knowledge of the basic biological mechanisms underlying these processes. It has become increasingly to be similar in complexity. One of the major goals of the Center for the Neurobiological Investigation of Drug Abuse is to provide an environment for scientific interactions to occur between NIDA funded investigators. The broad range of research expertise on drug abuse issues in the Center spans from the basic molecular mechanisms of drug action, to the consequences of drug abuse in humans. The research areas involved include: receptor coupling mechanisms; receptor binding; patch clamp techniques; neurochemistry; neuroendocrinology; behavioral neurophysiology; microdialysis; behavioral pharmacology; medication development and assessment; and positron emission tomography. This expertise in drug abuse research will be applied to targeted Projects dealing with contemporary issues to be realized through Core supported laboratories, permitting new directions and levels of collaboration that would not otherwise be possible. Training in neurobiological methods applied to the investigation of drug abuse will occur at both the predoctoral and postdoctoral levels. The Center will also serve as a resource to the public by providing information concerning the basic mechanisms of the actions of abused substances. The establishment of this Center will permit a comprehensive research, training and service environment focused on collaborative investigations of neurobiological mechanisms of drug abuse.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Specialized Center (P50)
Project #
1P50DA006634-01A1
Application #
3105448
Study Section
Special Emphasis Panel (SRCD (49))
Project Start
1991-09-30
Project End
1994-08-31
Budget Start
1991-09-30
Budget End
1992-08-31
Support Year
1
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Wake Forest University Health Sciences
Department
Type
Schools of Medicine
DUNS #
041418799
City
Winston-Salem
State
NC
Country
United States
Zip Code
27106
Siciliano, Cody A; Saha, Kaustuv; Calipari, Erin S et al. (2018) Amphetamine Reverses Escalated Cocaine Intake via Restoration of Dopamine Transporter Conformation. J Neurosci 38:484-497
Ilyasov, Alexander A; Milligan, Carolanne E; Pharr, Emily P et al. (2018) The Endocannabinoid System and Oligodendrocytes in Health and Disease. Front Neurosci 12:733
Ding, Huiping; Kiguchi, Norikazu; Yasuda, Dennis et al. (2018) A bifunctional nociceptin and mu opioid receptor agonist is analgesic without opioid side effects in nonhuman primates. Sci Transl Med 10:
Chen, R; McIntosh, S; Hemby, S E et al. (2018) High and low doses of cocaine intake are differentially regulated by dopamine D2 receptors in the ventral tegmental area and the nucleus accumbens. Neurosci Lett 671:133-139
John, William S; Martin, Thomas J; Solingapuram Sai, Kiran Kumar et al. (2018) Chronic ?9-THC in Rhesus Monkeys: Effects on Cognitive Performance and Dopamine D2/D3 Receptor Availability. J Pharmacol Exp Ther 364:300-310
Deadwyler, Sam A; Hampson, Robert E; Song, Dong et al. (2017) A cognitive prosthesis for memory facilitation by closed-loop functional ensemble stimulation of hippocampal neurons in primate brain. Exp Neurol 287:452-460
John, William S; Nader, Michael A (2017) Effects of ethanol on cocaine self-administration in monkeys responding under a second-order schedule of reinforcement. Drug Alcohol Depend 170:112-119
Blume, Lawrence C; Patten, Theresa; Eldeeb, Khalil et al. (2017) Cannabinoid Receptor Interacting Protein 1a Competition with ?-Arrestin for CB1 Receptor Binding Sites. Mol Pharmacol 91:75-86
Wesley, Michael J; Lile, Joshua A; Fillmore, Mark T et al. (2017) Neurophysiological capacity in a working memory task differentiates dependent from nondependent heavy drinkers and controls. Drug Alcohol Depend 175:24-35
John, William S; Martin, Thomas J; Nader, Michael A (2017) Behavioral Determinants of Cannabinoid Self-Administration in Old World Monkeys. Neuropsychopharmacology 42:1522-1530

Showing the most recent 10 out of 310 publications